Ensysce Biosciences Inc. (ENSC): Net earnings per share growth forecast for next year

Corporate company logo of Ensysce (ENSC)

Ensysce Biosciences (ENSC) adheres to basic environmental standards within its laboratories. This chart on GURU.Markets reflects the projected EPS growth for the coming year, where the value 89.30 determines the metric's magnitude. The company's potential is based on the TAAP platform and the clinical trials of the PF614 drug, although strict regulatory oversight and complex testing create significant barriers to development.

Ensysce Biosciences (ENSC): Consensus forecast of earnings per share growth for next year from 07/04/2022 to 11/11/2026

ENSC (Ensysce Biosciences, Inc.): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Stock Price Ensysce Biosciences Inc.|ENSC - Average Forecast Price
- stock exchange capitalization data:
Market Value Ensysce Biosciences|ENSC - Business Value
- company book value details:
Net Assets per Single Share Ensysce Biosciences|ENSC - Book Valuation of Business|Market Cap to Net Assets Ratio ensysce.com|ENSC - Company Assets
- debt obligations and liquidity statistics:
Debt to Equity Ensysce Biosciences|ENSC - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Ensysce Biosciences Inc.|ENSC - Company Total Debt|Debts to Book Capitalization Ensysce Biosciences|ENSC - Long-Term Debt|Company Current Liabilities Ensysce Biosciences|Quick Ratio ensysce.com
- net income and valuation ratios data:
ENSC - Company Net Income|Projected Future Earnings Ensysce Biosciences|ENSC - Business Payback Period|Future Price to Earnings Ensysce Biosciences Inc.|ENSC - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Ensysce Biosciences|ENSC - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Ensysce Biosciences|ENSC - Net earnings per share for the last 12 months|Quarterly EPS earnings growth ensysce.com|ENSC - Expected net earnings per share growth this year|Earnings growth forecast for next year Ensysce Biosciences
Comprehensive company analysis:Ensysce Biosciences, ENSC
Core merchandise of Ensysce Biosciences, Inc.

This indicator measures expected earnings momentum for the upcoming period, reflecting the analysts' consensus forecast regarding operational efficiency and business scaling rates. For Ensysce Biosciences (ENSC), which relies on external contractors (CRO/CMO), the analysts' assessment of net income dynamics for period n+1 becomes a critical indicator of how capitalization depends on outsourcing success and the precision of clinical timelines.

Competitors of Ensysce Biosciences

INDV (Indivior Group) - Earnings growth forecast for next year|Expected net earnings per share growth next year Collegium Corp COLL|Net earnings per share growth forecast for next year Cronos Group Inc. (CRON)|canopygrowth.com - Projected earnings per share growth rate for next year|Net earnings per share growth forecast for next year High Tide HITI|Consensus forecast of earnings per share growth for next year Aurora Cannabis, Inc. (ACB)|ACHV: Expected earnings per share growth for next year|Expected net earnings per share growth next year Skye Bioscience Inc.|Anebulo Pharmaceuticals (ANEB) - Net earnings per share growth forecast for next year|INCR - Consensus forecast of earnings per share growth for next year|NTRB (Nutriband Inc) - Earnings growth forecast for next year|Expected earnings per share growth for next year Nasus Pharma, Ltd. (NSRX)|Earnings growth forecast for next year IGC|MIRA - Expected net earnings per share growth next year|Flora Growth Corp. - Expected earnings per share growth for next year|Expected earnings per share trend next year IMCC|Adial - Earnings growth forecast for next year|ARTL: Net earnings per share growth forecast for next year|TTNP: Earnings growth forecast for next year|GNLN - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year InMed Pharmaceuticals|Expected net earnings per share growth next year akandacorp.com AKAN|Net earnings per share growth forecast for next year Enveric Biosciences, Inc. (ENVB)|Consensus forecast of earnings per share growth for next year brightgreen.us|Earnings growth forecast for next year HPCO (Hempacco Co., Inc.)